| Literature DB >> 28962670 |
Angel Esteban-Gil1, Jesualdo Tomás Fernández-Breis2, Martin Boeker3.
Abstract
BACKGROUND: Regional and epidemiological cancer registries are important for cancer research and the quality management of cancer treatment. Many technological solutions are available to collect and analyse data for cancer registries nowadays. However, the lack of a well-defined common semantic model is a problem when user-defined analyses and data linking to external resources are required. The objectives of this study are: (1) design of a semantic model for local cancer registries; (2) development of a semantically-enabled cancer registry based on this model; and (3) semantic exploitation of the cancer registry for analysing and visualising disease courses.Entities:
Keywords: Biomedical informatics; Cancer registry; Ontology; Semantic web
Mesh:
Year: 2017 PMID: 28962670 PMCID: PMC5622544 DOI: 10.1186/s13326-017-0154-9
Source DB: PubMed Journal: J Biomed Semantics
Fig. 1Schema of probability distribution of diagnoses and therapies
Fig. 2Schema of semantic profile of a cancer patient
Fig. 3Overview of the generation of aggregated disease timeline of a patient group
Fig. 4Example of semantic dashboard
OQuaRE Metrics for the Cancer Registry ontology
| Subcharacteristic | Value |
|---|---|
| Compatibility (3.25) | |
| Replaceability | 3.5 |
| Functional Adequacy (4.69) | |
| Clustering and Similarity | 4.5 |
| Consistent Search and query | 4.8 |
| Controlled Vocabulary | 5.0 |
| Guidance and Decision Trees | 5.0 |
| Indexing and Linking | 4.67 |
| Infering | 5.0 |
| Knowledge Acquisition | 4.67 |
| Knowledge Reuse | 4.875 |
| Reference Ontology | 4.5 |
| Results Representation | 3.5 |
| Schema and Value Reconciliation | 4.75 |
| Text Analysis | 5.0 |
| Maintainability (4.34) | |
| Analysability | 4.33 |
| Changeability | 3.86 |
| Modification Stability | 4.0 |
| Modularity | 5.0 |
| Reusability | 4.5 |
| Testeability | 4.33 |
| Operability (4.83) | |
| Learneability | 4.83 |
| Reliability (3.0) | |
| Availability | 4.0 |
| Recoverability | 2.0 |
| Structural (4.67) | |
| Cohesion | 4.0 |
| Consistency | 5.0 |
| Formal Relation Support | 4.0 |
| Formalisation | 5.0 |
| Redundancy | 5.0 |
| Tagledness | 5.0 |
| Transferability (4.25) | |
| Adaptability | 4.25 |
Fig. 5Overview of the system
Results of the migration of the relational database to the semantic data store
| Query | SQL | SQL | SPARQL | SPARQL |
|---|---|---|---|---|
| count | time | count | time | |
| result | result | |||
| Recovery all Patients | 207.190 | 0,060s | 207.190 | 0,189s |
| Recovery all Therapies | 400.290 | 0,132s | 400.290 | 0,317s |
| Recovery all Diagnosis | 240.088 | 0,070s | 240.088 | 0,220s |
| Recovery all Courses | 108.297 | 0,030s | 108.297 | 0,155s |
| Recovery patients with diagnosis, therapies and courses | 207.190 | 1,048s | 207.190 | 0,204s |
| Recovery all female Patients | 105.714 | 0,231s | 105.714 | 0,189s |
| Recovery all female Patients with more of 60 years old | 62.603 | 0,245s | 62.603 | 0,192s |
Fig. 6Dashboard view
SPARQL query generated by ODS for a dashboard
| PREFIX ods: 〈http://www.imib.es/ontologies/disease-times 〉 |
| SELECT count(DISTINCT ?s), ?t WHERE |
| {{?s rdf:type ?t FILTER (?t IN (ods:DrugTherapy, ods:Anti-hormoneTherapy, |
| ods:Anti-hormonal_anti-androgens, ods:Anti-hormonal_anti-estrogens, |
| ods:Anti-hormone_therapy_aromatase, ods:Other_Anti-hormoneTherapy, |
| ods:Chemotherapy, ods:Immunotherapy, ods:OtherdrugTherapy, |
| ods:Bisphosphonates, ods:Other_med_therapy, |
| ods:NuclearMedicineTherapy, ods:OpenRadionuclides, |
| ods:Other_nuclear_medicine_therapy, ods:RadioiodineTherapy, |
| ods:OtherTherapy, ods:Hyperthermia, ods:Locoregional_hyperthermia, |
| ods:Part-body_hyperthermia, ods:LightTherapy, ods:OtherLightTherapy, |
| ods:Selective_ultraviolet_phototherapy, ods:Wait_and_see, |
| ods:Radiotherapy, ods:Brachytherapy, ods:Interstitial_brachytherapy, |
| ods:Other_brachytherapy, ods:OtherHigh-voltageRadiotherapy, |
| ods:High-voltage_radiotherapy_n.n.bez., |
| ods:Other_high-voltage_radiotherapy, ods:Whole-body_irradiation, |
| ods:Teletherapy, ods:OtherTeletherapy, ods:Teletherapy_n.n.bez., |
| ods:Teletherapy_with_linear_accelerator, ods:StemCellTransplantation, |
| ods:AllogeneicSCT, ods:AutologousSCT, ods:SurgicalTreatment, |
| ods:Therapy))}. |
| {{?s ods:hasDiagnosis ?a0. |
| {?a0 rdf:type ?ta0 FILTER (?ta0 IN (ods:Diagnosis))} }. |
| {?a0 ods:hasPathologicalStructure ?a01. |
| {?a01 rdf:type ?ta01 FILTER (?ta01 IN (ods:Colorectal_cancer))} }. |
| {?s ods:hasPatient ?a1. {?a1 rdf:type ?ta1 FILTER (?ta1 IN (ods:Patient))} }. |
| {?a1 ods:age ?a12. FILTER (?a12 〉= 60)} }} group by ?t} |
Fig. 7Excerpt of the timeline representation
Fig. 8Ontology-driven searcher view
SPARQL query generated by ODS for a filter
| PREFIX ods: 〈http://www.imib.es/ontologies/disease-times 〉 |
| SELECT DISTINCT ?s WHERE { |
| {?s rdf:type ?t FILTER (?t IN (ods:Patient))}. |
| { |
| {?s ods:hasDiagnosis ?a0. |
| {?a0 rdf:type ?ta0 FILTER (?ta0 IN (ods:Diagnosis))} |
| }. {?a0 ods:hasPathologicalStructure ?a01. |
| {?a01 rdf:type ?ta01 FILTER (?ta01 IN (ods:Colorectal_cancer))} |
| }. {?s ods:gender ?a1. FILTER (str(?a1) = ’M’)}. |
| {?s ods:age ?a2. FILTER (?a2 〉= 50)}. |
| {?s ods:age ?a3. FILTER (?a3 〈= 70)}. |
| {?s ods:hasTherapy ?a4. |
| {?a4 rdf:type ?ta4 FILTER (?ta4 IN (ods:Chemotherapy))} |
| } |
| } |
| } |
Fig. 9Excerpt of the aggregated disease timeline of a patient group
Term enrichment for ICD10 cores of Lung cancer
| ICD 10 Code |
|
|
|---|---|---|
| Male | Female | |
| (308) | (152) | |
| C34.0 (Main bronchus) | 0.77 | 0.35 |
| C34.1 (Upper lobe, bronchus or lung) | 0.42 | 0.77 |
| C34.2 (Middle lobe, bronchus or lung) | 0.48 | 0.58 |
| C34.3 (Lower lobe, bronchus or lung) | 0.71 | 0.45 |
| C34.8 (Overlapping lesion of bronchus and lung) | 0.51 | 0.63 |
| C34.9 (Bronchus or lung, unspecified) | 0.55 | 0.40 |
Term enrichment for ICD10 cores of colorectal cancer
| ICD 10 Code |
|
|
|---|---|---|
| Male | Female | |
| (175) | (127) | |
| C17.0 (Duodenum) | 0.21 | 0.90 |
| C17.1 (Jejunum) | 0.31 | 0 |
| C17.2 (Ileum) | 0.94 | 0.47 |
| C17.8 (Overlapping lesion of small intestine) | 0 | 0.41 |
| C17.9 (Small intestine, unspecified) | 0.81 | 0.65 |
| C18.0 (Caecum) | 0.99 | 0.03 |
| C18.1 (Appendix) | 0.86 | 0.28 |
| C18.2 (Ascending colon) | 0.90 | 0.26 |
| C18.3 (Hepatic flexure) | 0.11 | 0.96 |
| C18.4 (Transverse colon) | 0.15 | 0.93 |
| C18.5 (Splenic flexure) | 0.59 | 0.79 |
| C18.6 (Descending colon) | 0.86 | 0.30 |
| C18.7 (Sigmoid colon) | 0.94 | 0.18 |
| C18.9 (Colon, unspecified) | 0.37 | 0.75 |
| C19 (Malignant neoplasm of rectosigmoid junction) | 0.96 | 0.18 |
| C20 (Malignant neoplasm of rectum) | 6.39E-4 | 0.99 |
| C21.0 (Anus, unspecified) | 0.98 | 0.18 |
| C21.1 (Anal canal) | 0.87 | 0.30 |
| C21.8 (Overlapping lesion of rectum, anus and anal canal) | 0 | 0.07 |
| D01.0 (Colon) | 0.81 | 0.65 |
| D01.2 (Rectum) | 0.56 | 0 |